Atara Biotherapeutics (ATRA) Stock Forecast for 2024–2028. Sell or Buy Prediction







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Atara Biotherapeutics (ATRA) Stock Forecast for 2024–2028. Sell or Buy?

Updated: July 24, 2024 (02:54)

Sector: Healthcare

The share price of Atara Biotherapeutics, Inc. (ATRA) now

Latest session on the 23rd of July for
Atara Biotherapeutics, Inc. is positive
Trading Volume: 36526
Open: 10.13 /  High: 10.62 /  Low: 10.13
What analysts predict: $104
52-week High/Low: $63.38 / $4.965

50/200 Day Moving Average: $12.16 / $17.98

This figure corresponds to the Average Price over the previous 50/200 days. For Atara Biotherapeutics stocks, the 50-day moving average is the resistance level today.

For Atara Biotherapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in Atara Biotherapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Atara Biotherapeutics stock price in 2024, 2025, 2026, 2027, 2028. How much will one Atara Biotherapeutics share be worth in 2024 - 2028?

When should I take profit in Atara Biotherapeutics stock? When should I record a loss on Atara Biotherapeutics stock? What are analysts' forecasts for Atara Biotherapeutics stock? What is the future of Atara Biotherapeutics stock? We forecast Atara Biotherapeutics stock performance using neural networks based on historical data on Atara Biotherapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Atara Biotherapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Atara Biotherapeutics shares. This happens once a day.


Historical and forecast chart of Atara Biotherapeutics stock

The chart below shows the historical price of Atara Biotherapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Atara Biotherapeutics stock price can be found in the table below.

Long-term forecasts by years.

Atara Biotherapeutic, Inc., a turnkey T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. He is developing tabelecleucel, a T-cell immunotherapy phase III clinical trial for the treatment of rituximab-refractory Epstein-Barr virus (EBV) associated with post-transplant lymphoproliferative disorder, as well as other EBV-related hematological and solid tumors, including carcinoma of the nasopharynx. The company is also developing next-generation CAR T immunotherapy for patients with hematologic malignancies and solid tumors, as well as viral diseases, including ATA2271 and ATA3271 for mesothelin; and ATA2431 and ATA3219 For B-cell lymphomas, and ATA188, which are in phase I clinical trials for the treatment of multiple sclerosis. He also develops ATA2321 for acute myeloid leukemia; ATA230 for cytomegalovirus; ATA368 for HPV; ATA520 for Wilms tumor 1; and ATA621 for BK and JCV. The company has a licensing agreement with the Sloan Kettering Memorial Cancer Center; a license agreement for cooperation in research and development with the Kimr Berghofer Medical Research Institute; and strategic cooperation with the H. Lee Moffitt Cancer Center. Atara Biotherapeutic, Inc. The company was founded in 2012 and is headquartered in South San Francisco, California.

Atara Biotherapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
Jul 25 10.62 10.49 10.72 2.16
Jul 26 10.47 10.32 10.67 3.44
Jul 27 10.58 10.46 10.72 2.43
Jul 28 10.45 10.33 10.69 3.49
Jul 29 10.73 10.63 10.83 1.94
Jul 30 10.85 10.60 10.98 3.53
Jul 31 10.93 10.67 11.15 4.49
Aug 01 10.88 10.75 11.14 3.58
Aug 02 10.60 10.53 10.77 2.26
Aug 03 10.55 10.35 10.66 3.00
Aug 04 10.66 10.59 10.85 2.39
Aug 05 10.97 10.81 11.15 3.14
Aug 06 11.16 11.09 11.23 1.27
Aug 07 11.05 10.88 11.20 2.95
Aug 08 10.96 10.84 11.08 2.28
Aug 09 11.19 11.12 11.44 2.90
Aug 10 11.08 10.98 11.31 3.03
Aug 11 11.36 11.27 11.58 2.78
Aug 12 11.18 11.09 11.36 2.45
Aug 13 11.09 10.84 11.16 3.01
Aug 14 11.05 10.80 11.28 4.39
Aug 15 10.93 10.71 11.06 3.25
Aug 16 10.87 10.71 10.97 2.47
Aug 17 10.98 10.81 11.06 2.38
Aug 18 10.90 10.81 10.99 1.66
Aug 19 10.97 10.73 11.08 3.31
Aug 20 11.11 10.95 11.19 2.16
Aug 21 11.26 11.11 11.47 3.28
Aug 22 11.17 10.98 11.36 3.42
Aug 23 10.87 10.69 11.00 2.96

Atara Biotherapeutics Daily Price Targets


Atara Biotherapeutics Stock Forecast 07-25-2024.

Forecast target price for 07-25-2024: $10.62.
Positive dynamics for Atara Biotherapeutics shares will prevail with possible volatility of 2.110%.
Pessimistic target level: 10.49
Optimistic target level: 10.72

Atara Biotherapeutics Stock Forecast 07-26-2024.

Forecast target price for 07-26-2024: $10.47.
Negative dynamics for Atara Biotherapeutics shares will prevail with possible volatility of 3.326%.
Pessimistic target level: 10.32
Optimistic target level: 10.67

Atara Biotherapeutics Stock Forecast 07-27-2024.

Forecast target price for 07-27-2024: $10.58.
Positive dynamics for Atara Biotherapeutics shares will prevail with possible volatility of 2.369%.
Pessimistic target level: 10.46
Optimistic target level: 10.72

Atara Biotherapeutics Stock Forecast 07-28-2024.

Forecast target price for 07-28-2024: $10.45.
Negative dynamics for Atara Biotherapeutics shares will prevail with possible volatility of 3.372%.
Pessimistic target level: 10.33
Optimistic target level: 10.69

Atara Biotherapeutics Stock Forecast 07-29-2024.

Forecast target price for 07-29-2024: $10.73.
Positive dynamics for Atara Biotherapeutics shares will prevail with possible volatility of 1.901%.
Pessimistic target level: 10.63
Optimistic target level: 10.83

Atara Biotherapeutics Stock Forecast 07-30-2024.

Forecast target price for 07-30-2024: $10.85.
Positive dynamics for Atara Biotherapeutics shares will prevail with possible volatility of 3.410%.
Pessimistic target level: 10.60
Optimistic target level: 10.98

ATRA (ATRA) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Aug. 11.21 10.93 11.80 7.41
Sep. 12.47 11.96 13.40 10.72
Oct. 11.93 11.00 12.69 13.31
Nov. 11.38 11.07 12.32 10.08
Dec. 11.58 11.18 12.27 8.94

Atara Biotherapeutics forecast for this year


Atara Biotherapeutics Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $11.2082. Pessimistic: $10.93. Optimistic: $11.80


Atara Biotherapeutics Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $12.4725. Pessimistic: $11.96. Optimistic: $13.40


Atara Biotherapeutics Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $11.9337. Pessimistic: $11.00. Optimistic: $12.69


Atara Biotherapeutics Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $11.3752. Pessimistic: $11.07. Optimistic: $12.32


Atara Biotherapeutics Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $11.5799. Pessimistic: $11.18. Optimistic: $12.27



Atara Biotherapeutics (ATRA) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 11.68 10.74 12.01 10.61
Feb 11.96 11.54 12.32 6.29
Mar 12.23 11.86 13.32 10.91
Apr 12.83 11.97 13.80 13.28
May 12.15 11.80 12.84 8.07
Jun 11.79 11.27 12.40 9.13
Jul 12.31 11.31 13.14 13.94
Aug 12.58 11.79 13.62 13.41
Sep 11.82 10.69 12.35 13.44
Oct 11.16 10.55 12.19 13.40
Nov 12.27 11.78 13.36 11.79
Dec 13.59 13.17 14.00 5.94

Atara Biotherapeutics (ATRA) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 14.41 13.37 14.82 9.80
Feb 15.62 14.21 17.10 16.88
Mar 14.46 13.21 15.53 14.97
Apr 13.66 12.61 14.69 14.17
May 13.32 12.39 13.84 10.50
Jun 12.77 11.62 13.34 12.87
Jul 12.68 12.06 13.01 7.37
Aug 13.36 12.10 14.33 15.56
Sep 14.21 13.33 15.53 14.17
Oct 13.48 12.38 13.87 10.73
Nov 12.70 11.55 13.03 11.35
Dec 13.12 12.53 14.06 10.86

Atara Biotherapeutics (ATRA) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 12.82 11.68 13.92 16.13
Feb 12.37 11.60 13.43 13.60
Mar 12.21 11.21 12.72 11.86
Apr 12.76 12.31 13.07 5.86
May 12.93 12.22 13.83 11.67
Jun 13.83 13.02 14.23 8.51
Jul 13.24 12.70 13.65 6.98
Aug 12.57 12.16 13.65 10.94
Sep 12.64 11.90 13.52 12.00
Oct 13.84 13.51 14.18 4.69
Nov 13.39 12.59 14.66 14.14
Dec 12.41 11.83 13.44 11.97

Atara Biotherapeutics (ATRA) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 12.73 11.61 13.60 14.60
Feb 12.28 11.94 13.42 10.99
Mar 12.36 11.94 13.38 10.75
Apr 11.82 11.27 12.12 7.02
May 12.92 11.78 13.33 11.62
Jun 12.90 12.37 13.61 9.10
Jul 13.74 12.42 14.54 14.62
Aug 13.11 12.13 14.21 14.61
Sep 14.46 14.08 15.12 6.89
Oct 14.17 13.78 14.78 6.79
Nov 13.34 12.71 13.82 7.99
Dec 13.75 12.50 14.86 15.88

Atara Biotherapeutics information and performance

Atara Biotherapeutics Address

611 GATEWAY BLVD, SUITE 900, SOUTH SAN FRANCISCO, CA, US

Market Capitalization: 53 996 000 $

Market capitalization of the Atara Biotherapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ATRA shares in the company outstanding by the market price of one share.

EBITDA: -215 792 992 $

EBITDA of Atara Biotherapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -53

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 21.31
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 10.77

Enterprise Value (EV) /Revenue

EV To EBITDA: -0.347

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 4904300

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.